Functional analysis of atypical mutations in exons 13 and 15 of JAK2 gene in myeloproliferative neoplasms

被引：1

作者：

Luo, Ming ^{[1
]}

Tian, Tingting ^{[1
]}

Zhang, Yaofang ^{[1
]}

Zhang, Xialin ^{[1
]}

Xie, Juan ^{[1
]}

Xu, Jing ^{[1
]}

Ren, Weixiao ^{[1
]}

Tian, Chuchu ^{[1
]}

Wang, Jiaxuan ^{[1
]}

Tan, Yanhong ^{[1
]}

Wang, Hongwei ^{[1
]}

Chen, Xiuhua ^{[1
]}

机构：

[1] Shanxi Med Univ, Hosp 2, Inst Hematol, 382 Wuyi Rd, Taiyuan 030001, Peoples R China

来源：

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2021年 / 43卷 / 03期

基金：

中国国家自然科学基金;

关键词：

atypical mutation; JAK2; myeloproliferative neoplasms; PSEUDOKINASE DOMAIN;

D O I：

10.1111/ijlh.13398

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E110 / E113

页数：4

共 50 条

[21] Targeting JAK2 in the therapy of myeloproliferative neoplasms
Reddy, Mamatha M.
Deshpande, Anagha
Sattler, Martin
EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (03) : 313 - 324
[22] JAK2 INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS
Tefferi, A.
ANNALS OF ONCOLOGY, 2010, 21 : 20 - 21
[23] JAK2 in Myeloproliferative Neoplasms: Still a Protagonist
Bader, Michael Stephan
Meyer, Sara Christina
PHARMACEUTICALS, 2022, 15 (02)
[24] Therapy with JAK2 Inhibitors for Myeloproliferative Neoplasms
Santos, Fabio P. S.
Verstovsek, Srdan
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (05) : 1083 - +
[25] JAK2 Mutation and Thrombosis in the Myeloproliferative Neoplasms
Alessandro M. Vannucchi
Current Hematologic Malignancy Reports, 2010, 5 : 22 - 28
[26] JAK2 Mutation and Thrombosis in the Myeloproliferative Neoplasms
Vannucchi, Alessandro M.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (01) : 22 - 28
[27] New JAK2 inhibitors for myeloproliferative neoplasms
Quintas-Cardama, Alfonso
Verstovsek, Srdan
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (07) : 961 - 972
[28] JAK2 inhibitors in the treatment of myeloproliferative neoplasms
Tibes, Raoul
Bogenberger, James M.
Geyer, Holly L.
Mesa, Ruben A.
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (12) : 1755 - 1774
[29] JAK2 inhibitors and their impact in myeloproliferative neoplasms
Geyer, Holly L.
Tibes, Raoul
Mesa, Ruben A.
HEMATOLOGY, 2012, 17 : S129 - S132
[30] Detection of mutations in JAK2 exons 12-15 by Sanger sequencing
Alghasham, N.
Alnouri, Y.
Abalkhail, H.
Khalil, S.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 (01) : 34 - 41

← 1 2 3 4 5 →